PLG and radiodermatitis: Moreover, treatment with an inhibitor of plasminogen activation (tranexamic acid (TXA)) significantly delays the onset and decreases the severity of radiodermatitis in plg+/+ mice and completely prevents radiodermatitis in plg+/− mice.